0000929638-23-003339.txt : 20231204 0000929638-23-003339.hdr.sgml : 20231204 20231204175242 ACCESSION NUMBER: 0000929638-23-003339 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231130 FILED AS OF DATE: 20231204 DATE AS OF CHANGE: 20231204 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Daws D. Ryan CENTRAL INDEX KEY: 0001598602 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41854 FILM NUMBER: 231464578 MAIL ADDRESS: STREET 1: 99 HAYDEN AVENUE STREET 2: SUITE 500 CITY: LEXINGTON STATE: MA ZIP: 02421 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: enGene Holdings Inc. CENTRAL INDEX KEY: 0001980845 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: Z4 FISCAL YEAR END: 1031 BUSINESS ADDRESS: STREET 1: 4868 RUE LEVY, SUITE 220 CITY: SAINT-LAURENT STATE: A8 ZIP: H4R 2P1 BUSINESS PHONE: (514) 332-4888 MAIL ADDRESS: STREET 1: 4868 RUE LEVY, SUITE 220 CITY: SAINT-LAURENT STATE: A8 ZIP: H4R 2P1 4 1 form4.xml X0508 4 2023-11-30 0001980845 enGene Holdings Inc. ENGN 0001598602 Daws D. Ryan C/O 4868 RUE LEVY, SUITE 220 SAINT-LAURENT A8 H4R 2P1 QUEBEC, CANADA true Chief Financial Officer false Stock Option (Right to Buy) 7.66 2023-11-30 4 A 0 232000 0 A 2033-11-30 Common Shares 232000 232000 D This option vests at 25% on the first anniversary of the grant date, with the remaining portion to vest monthly over the remaining three years. /s/ D. Ryan Daws 2023-12-04